Nov 15 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- AUSTRALIAN CLINICAL LABS LTD - ENTERED INTO A BINDING AGREEMENT TO ACQUIRE MEDLAB PATHOLOGY
- AUSTRALIAN CLINICAL LABS LTD - DEAL WILL BE FUNDED BY CASH ON BALANCE SHEET AND EXISTING DEBT FACILITIES
- AUSTRALIAN CLINICAL LABS LTD - ACL WILL ACQUIRE KEY BUSINESS ASSETS FOR A$70M
- AUSTRALIAN CLINICAL LABS - EXPECTS TO GENERATE SYNERGY BENEFITS OF MORE THAN A$10 MILLION WHICH WILL TAKE 18 TO 24 MONTHS TO BE ACHIEVED ON RUN RATE BASIS
- AUSTRALIAN CLINICAL LABS - TRANSACTION WILL BE FUNDED BY CASH ON BALANCE SHEET AND EXISTING DEBT FACILITIES
- AUSTRALIAN CLINICAL LABS LTD - DEAL INCLUDES UPFRONT CONSIDERATION OF A$60 MILLION
News: ACL Australian Clinical Labs To Buy Medlab Pathology
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.54 |
Change
-0.080(3.05%) |
Mkt cap ! $498.8M | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.53 | $1.032M | 402.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 41152 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.54 | 616 | 10 |
View Market Depth
| Last trade - 13.52pm 09/09/2025 (20 minute delay) ? |
| ACL (ASX) Chart |